MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 210 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,577,470 | -66.9% | 157,747 | -58.8% | 0.00% | -100.0% |
Q2 2023 | $4,764,854 | -3.8% | 383,335 | +8.4% | 0.00% | 0.0% |
Q1 2023 | $4,954,791 | -11.6% | 353,661 | -9.7% | 0.00% | -50.0% |
Q4 2022 | $5,605,313 | -85.5% | 391,706 | -74.1% | 0.00% | -83.3% |
Q3 2022 | $38,643,000 | -7.8% | 1,513,641 | +2.6% | 0.01% | -7.7% |
Q2 2022 | $41,894,000 | -3.3% | 1,474,620 | +20.1% | 0.01% | +18.2% |
Q1 2022 | $43,304,000 | -22.9% | 1,227,783 | -8.4% | 0.01% | -21.4% |
Q4 2021 | $56,172,000 | -63.6% | 1,340,634 | -57.4% | 0.01% | -64.1% |
Q3 2021 | $154,304,000 | -11.7% | 3,143,904 | -24.9% | 0.04% | -9.3% |
Q2 2021 | $174,695,000 | +21.7% | 4,186,328 | +3.9% | 0.04% | +13.2% |
Q1 2021 | $143,548,000 | +29.5% | 4,027,738 | +1.9% | 0.04% | +18.8% |
Q4 2020 | $110,838,000 | – | 3,951,436 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |